(See the editorial commentary by Connick et al. on pages 1355–7) Background. The objective of this study was to identify the frequency and characteristics of patients with human immunodeficiency virus (HIV) infection who had spontaneously achieved viremia below the detection limit of either 400 or 500 copies/mL (depending on the test used) and to describe the duration of undetectable viremia without antiretroviral therapy (ART). Methods. In the French Agence Nationale de Recherches sur le SIDA SEROCO cohort, 426 patients with HIV seroconversion (i.e., seroconverters) enrolled between 1988 and 1995 had serial measurement of HIV RNA levels during follow-up (with a cutoff date of 31 December 2002). Factors that distinguished those patients who...
BackgroundPrevious cohort studies have demonstrated the beneficial effects of antiretroviral therapy...
Objective: Very-low-level viremia (VLLV) is a relatively new concept in the realm of human immunodef...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...
Laurence Meyera on behalf of the CASCADE CollaborationM Objectives: To identify factors associated w...
BACKGROUND: A vast majority of HIV-infected subjects who experience HIV acute seroconversion actuall...
Background: Combination antiretroviral therapy (cART), the standard of care for HIV-1 infection, is ...
BACKGROUND: Management of persistent low-level viraemia (pLLV) in patients on combined antiretrovira...
BACKGROUND: HIV-1 viremia is a major determinant of HIV-1 transmission at population level. We analy...
BACKGROUND: Low-level viremia (LLV) is measurable, with enhanced assays, in many subjects with HIV R...
Objective: To investigate immunologic, virologic, and clinical consequences of episodes of transient...
International audienceBACKGROUND:Given the great efforts put into the strategic objective of reducin...
Objective: To assess the risk of clinical progression (CP) according to the duration of time spent w...
OBJECTIVES: An article by the Swiss AIDS Commission states that patients with stably suppressed vira...
BACKGROUND: Management of persistent low-level viraemia (pLLV) in patients on combined antiretrovira...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
BackgroundPrevious cohort studies have demonstrated the beneficial effects of antiretroviral therapy...
Objective: Very-low-level viremia (VLLV) is a relatively new concept in the realm of human immunodef...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...
Laurence Meyera on behalf of the CASCADE CollaborationM Objectives: To identify factors associated w...
BACKGROUND: A vast majority of HIV-infected subjects who experience HIV acute seroconversion actuall...
Background: Combination antiretroviral therapy (cART), the standard of care for HIV-1 infection, is ...
BACKGROUND: Management of persistent low-level viraemia (pLLV) in patients on combined antiretrovira...
BACKGROUND: HIV-1 viremia is a major determinant of HIV-1 transmission at population level. We analy...
BACKGROUND: Low-level viremia (LLV) is measurable, with enhanced assays, in many subjects with HIV R...
Objective: To investigate immunologic, virologic, and clinical consequences of episodes of transient...
International audienceBACKGROUND:Given the great efforts put into the strategic objective of reducin...
Objective: To assess the risk of clinical progression (CP) according to the duration of time spent w...
OBJECTIVES: An article by the Swiss AIDS Commission states that patients with stably suppressed vira...
BACKGROUND: Management of persistent low-level viraemia (pLLV) in patients on combined antiretrovira...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
BackgroundPrevious cohort studies have demonstrated the beneficial effects of antiretroviral therapy...
Objective: Very-low-level viremia (VLLV) is a relatively new concept in the realm of human immunodef...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...